IsoRay's Innovative Internal Radiation Therapy and da Vinci Robotics Reduces Cancer Reoccurrence in Early Stage Lung Cancer Treatment
Atopic dermatitis (eczema) is a common skin disorder characterized by dry, cracked, itching and burning skin. Other symptoms may include blisters with oozing or crusting, changes in the skin tone and thickening of the skin called lichenification(1). Eczema frequently affects children, with approximately 10.7 percent of all children experiencing a diagnosis within the past 12 months, according to a recent study(2). Patients with eczema have a compromised skin barrier, allowing excessive water loss through the epidermal layer of skin and reducing its permeability.HylatopicPlus™ Cream is now available in the U.S. by prescription only."By using a well-formulated barrier repair cream that is recommended by your dermatologist as part of the overall treatment, the function and protective actions of the skin's top layer are maintained, response to other medications is enhanced, possible side effects of treatment are avoided and the skin responds faster," Dr. Del Rosso said. "The importance of this treatment approach continues to be observed in clinical studies and in day-to-day practice."For more information please visit our website at www.udetection.com .Universal Detection Technology (UNDT) is a developer of monitoring technologies, including chemical, biological, radiological, nuclear (CBRN), and mold detection devices. The company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. The Company is a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and chemical agent detectors. For more information, please visit www.udetection.com .About Atopic Dermatitis (Eczema)Headquartered in Cumberland, R.I., PreCision Dermatology ( www.precisionderm.com ) is a fully-integrated dermatology company with a mission to deliver innovative therapies to doctors and patients that demonstrably improve the care of skin. PreCision Dermatology is expanding quickly through acquisitions, in-licensing, co-marketing opportunities and internally generated therapies."HylatopicPlus™ Cream is an excellent example of a well-designed formulation which has been shown to restore the protective functions of the skin's top layer and maintain the necessary moisture level so that natural skin proteins can function properly, contributing to the overall treatment goal of normally functioning, healthy skin," Dr. Del Rosso said. "Studies also have demonstrated that the ingredient formulation used in HylatopicPlus™ Cream improves signs and symptoms of dry skin and eczema, such as roughness, scaling, flaking, redness and itching. I have never treated a patient who has not been happy when itching is relieved."About Onset Dermatologics
Statements in this news release about IsoRay's future expectations, including: the advantages of our Cesium-131 seed, the advantages of Cesium-131, the mesh brachytherapy application and the da Vinci® surgery system in lung cancer applications, whether IsoRay's Cesium-131 seed will be used to treat additional cancers and malignant disease, whether the use of Cesium-131 to treat lung cancers will be successful both long- and short-term in the initial and any future implants, and all other statements in this release, other than historical facts, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 ("PSLRA"). This statement is included for the express purpose of availing IsoRay, Inc. of the protections of the safe harbor provisions of the PSLRA. It is important to note that actual results and ultimate corporate actions could differ materially from those in such forward-looking statements based on such factors as physician acceptance, training and use of our products, our ability to successfully manufacture, market and sell our products, our ability to manufacture our products in sufficient quantities to meet demand within required delivery time periods while meeting our quality control standards, our ability to enforce our intellectual property rights, whether additional studies are released and support the conclusions of early clinical studies, whether implants of Cesium-131 to treat lung cancers result in favorable patient outcomes, patient results achieved when Cesium-131 is used for the treatment of cancers and malignant diseases beyond prostate cancer, whether hospitals, medical treatment centers and physicians continue to adopt Cs-131 mesh brachytherapy used in conjunction with the da Vinci® surgical system to treat early stage lung cancers, successful completion of future research and development activities, and other risks detailed from time to time in IsoRay's reports filed with the SEC.
No comments:
Post a Comment